Joshua D. Grill - Publications

Affiliations: 
2004 Wake Forest University School of Medicine, Winston-Salem, NC, United States 

30/72 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2016 Chang TS, Teng E, Elashoff D, Grill JD. Optimizing Effect Sizes With Imaging Enrichment and Outcome Choices for Mild Alzheimer Disease Clinical Trials. Alzheimer Disease and Associated Disorders. PMID 27196535 DOI: 10.1097/WAD.0000000000000150  0.48
2016 Grill JD, Zhou Y, Elashoff D, Karlawish J. Disclosure of amyloid status is not a barrier to recruitment in preclinical Alzheimer's disease clinical trials. Neurobiology of Aging. 39: 147-53. PMID 26923411 DOI: 10.1016/j.neurobiolaging.2015.11.007  0.48
2015 Grill JD, Karlawish J. Consider the Source: The Implications of Informant Type on Outcome Assessments. Alzheimer Disease and Associated Disorders. 29: 364. PMID 26485500 DOI: 10.1097/WAD.0000000000000109  0.48
2015 Henley DB, Dowsett SA, Chen YF, Liu-Seifert H, Grill JD, Doody RS, Aisen P, Raman R, Miller DS, Hake AM, Cummings J. Alzheimer's disease progression by geographical region in a clinical trial setting. Alzheimer's Research & Therapy. 7: 43. PMID 26120369 DOI: 10.1186/s13195-015-0127-0  0.48
2015 Grill JD, Raman R, Ernstrom K, Aisen P, Dowsett SA, Chen YF, Liu-Seifert H, Hake AM, Miller DS, Doody RS, Henley DB, Cummings JL. Comparing recruitment, retention, and safety reporting among geographic regions in multinational Alzheimer's disease clinical trials. Alzheimer's Research & Therapy. 7: 39. PMID 26120368 DOI: 10.1186/s13195-015-0122-5  0.48
2015 Grill JD, Vinters HV, Monsell SE. Does Alzheimer Disease Pathologic Change Underlie Subjective Cognitive Complaints? Alzheimer Disease and Associated Disorders. PMID 25973910 DOI: 10.1097/WAD.0000000000000092  0.48
2015 Harkins K, Sankar P, Sperling R, Grill JD, Green RC, Johnson KA, Healy M, Karlawish J. Development of a process to disclose amyloid imaging results to cognitively normal older adult research participants. Alzheimer's Research & Therapy. 7: 26. PMID 25969699 DOI: 10.1186/s13195-015-0112-7  0.48
2015 Jennings LA, Reuben DB, Evertson LC, Serrano KS, Ercoli L, Grill J, Chodosh J, Tan Z, Wenger NS. Unmet needs of caregivers of individuals referred to a dementia care program. Journal of the American Geriatrics Society. 63: 282-9. PMID 25688604 DOI: 10.1111/jgs.13251  0.48
2015 Hsiao JJ, Lu PH, Grill JD, Teng E. Longitudinal declines in instrumental activities of daily living in stable and progressive mild cognitive impairment. Dementia and Geriatric Cognitive Disorders. 39: 12-24. PMID 25300404 DOI: 10.1159/000365587  0.48
2015 Cary MS, Rubright JD, Grill JD, Karlawish J. Why are spousal caregivers more prevalent than nonspousal caregivers as study partners in AD dementia clinical trials? Alzheimer Disease and Associated Disorders. 29: 70-4. PMID 24805971 DOI: 10.1097/WAD.0000000000000047  0.48
2015 Grill JD, Bateman RJ, Buckles V, Oliver A, Morris JC, Masters CL, Klunk WE, Ringman JM. A survey of attitudes toward clinical trials and genetic disclosure in autosomal dominant Alzheimer's disease Alzheimer's Research and Therapy. 7. DOI: 10.1186/s13195-015-0135-0  0.48
2014 Grill JD, Zhou Y, Karlawish J, Elashoff D. Frequency and Impact of Informant Replacement in Alzheimer Disease Research. Alzheimer Disease and Associated Disorders. PMID 25551863 DOI: 10.1097/WAD.0000000000000078  0.48
2014 Grill JD, Galvin JE. Facilitating Alzheimer disease research recruitment. Alzheimer Disease and Associated Disorders. 28: 1-8. PMID 24322484 DOI: 10.1097/WAD.0000000000000016  0.48
2014 Grill JD, Monsell SE. Choosing Alzheimer's disease prevention clinical trial populations. Neurobiology of Aging. 35: 466-71. PMID 24119546 DOI: 10.1016/j.neurobiolaging.2013.09.001  0.48
2014 Grill JD, Zhou Y, Karlawish J, Elashoff D. Does study partner type impact the rate of Alzheimer's disease progression? Journal of Alzheimer's Disease : Jad. 38: 507-14. PMID 23985417 DOI: 10.3233/JAD-131052  0.48
2013 Kohannim O, Hua X, Rajagopalan P, Hibar DP, Jahanshad N, Grill JD, Apostolova LG, Toga AW, Jack CR, Weiner MW, Thompson PM. Multilocus genetic profiling to empower drug trials and predict brain atrophy. Neuroimage. Clinical. 2: 827-35. PMID 24179834 DOI: 10.1016/j.nicl.2013.05.007  0.48
2013 Hooper M, Grill JD, Rodriguez-Agudelo Y, Medina LD, Fox M, Alvarez-Retuerto AI, Wharton D, Brook J, Ringman JM. The impact of the availability of prevention studies on the desire to undergo predictive testing in persons at risk for autosomal dominant Alzheimer's disease. Contemporary Clinical Trials. 36: 256-62. PMID 23876673 DOI: 10.1016/j.cct.2013.07.006  0.48
2013 Grill JD, Raman R, Ernstrom K, Aisen P, Karlawish J. Effect of study partner on the conduct of Alzheimer disease clinical trials. Neurology. 80: 282-8. PMID 23255824 DOI: 10.1212/WNL.0b013e31827debfe  0.48
2013 Grill JD, Karlawish J, Elashoff D, Vickrey BG. Risk disclosure and preclinical Alzheimer's disease clinical trial enrollment. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 9: 356-359.e1. PMID 23141383 DOI: 10.1016/j.jalz.2012.03.001  0.48
2013 Grill JD, Di L, Lu PH, Lee C, Ringman J, Apostolova LG, Chow N, Kohannim O, Cummings JL, Thompson PM, Elashoff D. Estimating sample sizes for predementia Alzheimer's trials based on the Alzheimer's Disease Neuroimaging Initiative. Neurobiology of Aging. 34: 62-72. PMID 22503160 DOI: 10.1016/j.neurobiolaging.2012.03.006  0.48
2012 Grill JD, Monsell S, Karlawish J. Are patients whose study partners are spouses more likely to be eligible for Alzheimer's disease clinical trials? Dementia and Geriatric Cognitive Disorders. 33: 334-40. PMID 22759982 DOI: 10.1159/000339361  0.48
2012 Grill JD, Cummings J. Alzheimer’s disease Clinical Trials in Neurology: Design, Conduct, Analysis. 227-241. DOI: 10.1017/CBO9781139032445.022  0.48
2011 Grill JD, Ringman JM. Should persons with autosomal dominant AD be included in clinical trials? Alzheimer's Research & Therapy. 3: 18. PMID 21609419 DOI: 10.1186/alzrt80  0.48
2010 Grill JD, Karlawish J. Addressing the challenges to successful recruitment and retention in Alzheimer's disease clinical trials. Alzheimer's Research & Therapy. 2: 34. PMID 21172069 DOI: 10.1186/alzrt58  0.48
2010 Grill JD, Cummings JL. Current therapeutic targets for the treatment of Alzheimer's disease. Expert Review of Neurotherapeutics. 10: 711-28. PMID 20420492 DOI: 10.1586/ern.10.29  0.48
2009 Ringman JM, Grill J, Rodriguez-Agudelo Y, Chavez M, Xiong C. Commentary on "a roadmap for the prevention of dementia II: Leon Thal Symposium 2008." Prevention trials in persons at risk for dominantly inherited Alzheimer's disease: opportunities and challenges. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 5: 166-71. PMID 19328453 DOI: 10.1016/j.jalz.2008.12.002  0.48
2007 Robinson-Smith G, Grill JD. Recognizing involuntary emotional expression disorder. The Journal of Neuroscience Nursing : Journal of the American Association of Neuroscience Nurses. 39: 202-7. PMID 17847666 DOI: 10.1097/01376517-200708000-00003  0.48
2005 Grill JD, Sonntag WE, Riddle DR. Dendritic stability in a model of adult-onset IGF-I deficiency. Growth Hormone & Igf Research : Official Journal of the Growth Hormone Research Society and the International Igf Research Society. 15: 337-48. PMID 16143551 DOI: 10.1016/j.ghir.2005.07.002  0.48
2002 Grill JD, Riddle DR. Age-related and laminar-specific dendritic changes in the medial frontal cortex of the rat. Brain Research. 937: 8-21. PMID 12020857 DOI: 10.1016/S0006-8993(02)02457-5  0.48
2002 Grill JD, Coghill RC. Transient analgesia evoked by noxious stimulus offset. Journal of Neurophysiology. 87: 2205-8. PMID 11929939 DOI: 10.1152/jn.00730.2001  0.48
Low-probability matches
2020 Salazar CR, Hoang D, Gillen DL, Grill JD. Racial and ethnic differences in older adults' willingness to be contacted about Alzheimer's disease research participation. Alzheimer's & Dementia (New York, N. Y.). 6: e12023. PMID 32399482 DOI: 10.1002/trc2.12023  0.01
2019 Nuño MM, Gillen DL, Grill JD. Study partner types and prediction of cognitive performance: implications to preclinical Alzheimer's trials. Alzheimer's Research & Therapy. 11: 92. PMID 31775871 DOI: 10.1186/s13195-019-0544-6  0.01
2019 Ryan MM, Grill JD, Gillen DL. Participant and study partner prediction and identification of cognitive impairment in preclinical Alzheimer's disease: study partner vs. participant accuracy. Alzheimer's Research & Therapy. 11: 85. PMID 31627738 DOI: 10.1186/s13195-019-0539-3  0.01
2019 Grill JD, Kwon J, Teylan MA, Pierce A, Vidoni ED, Burns JM, Lindauer A, Quinn J, Kaye J, Gillen DL, Nan B. Retention of Alzheimer Disease Research Participants. Alzheimer Disease and Associated Disorders. PMID 31567302 DOI: 10.1097/WAD.0000000000000353  0.01
2019 Kent S, Bardach SH, Zhang X, Abner EL, Grill JD, Jicha GA. Public Understanding and Opinions regarding Genetic Research on Alzheimer's Disease. Public Health Genomics. 21: 228-237. PMID 31326966 DOI: 10.1159/000501464  0.01
2019 Grill JD, Cox CG, Harkins K, Karlawish J. Response to "Avoiding Methodological Bias in Studies of Amyloid Imaging Results Disclosure". Alzheimer's Research & Therapy. 11: 51. PMID 31159857 DOI: 10.1186/s13195-019-0504-1  0.01
2019 Grill JD, Nuño MM, Gillen DL. Which MCI Patients Should be Included in Prodromal Alzheimer Disease Clinical Trials? Alzheimer Disease and Associated Disorders. PMID 30958413 DOI: 10.1097/WAD.0000000000000303  0.01
2019 Camacho MR, Grill JD, Karlawish J, Rabinovici GD, Carrillo MC, Weiner MW, Nosheny RL. P1-351: COGNITIVELY IMPAIRED BRAIN HEALTH REGISTRY PARTICIPANTS’ ATTITUDES ABOUT THE VALUE OF AMYLOID PET RESULTS Alzheimer's & Dementia. 15: P385-P385. DOI: 10.1016/j.jalz.2019.06.906  0.01
2019 Cox CG, Gillen DL, Grill JD. WHY IS THE STUDY PARTNER REQUIREMENT A BARRIER TO RECRUITMENT IN PRECLINICAL ALZHEIMER’S DISEASE TRIALS? Alzheimer's & Dementia. 15: P176-P177. DOI: 10.1016/j.jalz.2019.06.4372  0.01
2019 Salazar CR, Hoang D, Gillen DL, Grill JD. RACIAL AND ETHNIC DIFFERENCES IN PARTICIPANTS’ WILLINGNESS TO BE CONTACTED ABOUT RESEARCH PARTICIPATION Alzheimer's & Dementia. 15: P244. DOI: 10.1016/j.jalz.2019.06.056  0.01
2018 Grill JD, Cox CG, Harkins K, Karlawish J. Reactions to learning a "not elevated" amyloid PET result in a preclinical Alzheimer's disease trial. Alzheimer's Research & Therapy. 10: 125. PMID 30579361 DOI: 10.1186/s13195-018-0452-1  0.01
2018 Cox CG, Ryan B A MM, Gillen DL, Grill JD. A Preliminary Study of Clinical Trial Enrollment Decisions Among People With Mild Cognitive Impairment and Their Study Partners. The American Journal of Geriatric Psychiatry : Official Journal of the American Association For Geriatric Psychiatry. PMID 30522811 DOI: 10.1016/j.jagp.2018.10.016  0.01
2018 Largent EA, Karlawish J, Grill JD. Study partners: essential collaborators in discovering treatments for Alzheimer's disease. Alzheimer's Research & Therapy. 10: 101. PMID 30261910 DOI: 10.1186/s13195-018-0425-4  0.01
2018 Torosyan N, Sethanandha C, Grill JD, Dilley ML, Lee J, Cummings JL, Ossinalde C, Silverman DH. Changes in regional cerebral blood flow associated with a 45 day course of the ketogenic agent, caprylidene, in patients with mild to moderate Alzheimer's disease: Results of a randomized, double-blinded, pilot study. Experimental Gerontology. PMID 30006299 DOI: 10.1016/j.exger.2018.07.009  0.01
2018 Melikyan ZA, Greenia DE, Corrada MM, Hester MM, Kawas CH, Grill JD. Recruiting the Oldest-old for Clinical Research. Alzheimer Disease and Associated Disorders. PMID 29734262 DOI: 10.1097/WAD.0000000000000260  0.01
2018 Grill JD, Hoang D, Gillen DL, Cox CG, Gombosev A, Klein K, O'Leary S, Witbracht M, Pierce A. Constructing a Local Potential Participant Registry to Improve Alzheimer's Disease Clinical Research Recruitment. Journal of Alzheimer's Disease : Jad. PMID 29710723 DOI: 10.3233/JAD-180069  0.01
2018 Pierce AL, Cox CG, Nguyen H, Hoang D, Witbracht M, Gillen DL, Grill JD. Participant Satisfaction With Learning Alzheimer Disease Clinical Trial Results. Alzheimer Disease and Associated Disorders. PMID 29683808 DOI: 10.1097/WAD.0000000000000258  0.01
2017 Grill JD, Karlawish J. Study partners should be required in preclinical Alzheimer's disease trials. Alzheimer's Research & Therapy. 9: 93. PMID 29212555 DOI: 10.1186/s13195-017-0327-x  0.01
2017 Zhou Y, Elashoff D, Kremen S, Teng E, Karlawish J, Grill JD. African Americans are less likely to enroll in preclinical Alzheimer's disease clinical trials. Alzheimer's & Dementia (New York, N. Y.). 3: 57-64. PMID 29067319 DOI: 10.1016/j.trci.2016.09.004  0.01
2017 Nuño MM, Gillen DL, Dosanjh KK, Brook J, Elashoff D, Ringman JM, Grill JD. Attitudes toward clinical trials across the Alzheimer's disease spectrum. Alzheimer's Research & Therapy. 9: 81. PMID 28978335 DOI: 10.1186/s13195-017-0311-5  0.01
2017 Grill JD, Apostolova LG, Bullain S, Burns JM, Cox CG, Dick M, Hartley D, Kawas C, Kremen S, Lingler J, Lopez OL, Mapstone M, Pierce A, Rabinovici G, Roberts JS, et al. Communicating mild cognitive impairment diagnoses with and without amyloid imaging. Alzheimer's Research & Therapy. 9: 35. PMID 28472970 DOI: 10.1186/s13195-017-0261-y  0.01
2017 Grill JD. Recruiting to preclinical Alzheimer's disease clinical trials through registries. Alzheimer's & Dementia (New York, N. Y.). 3: 205-212. PMID 28439532 DOI: 10.1016/j.trci.2017.02.004  0.01
2017 Grill JD, Cox CG, Kremen S, Mendez MF, Teng E, Shapira J, Ringman JM, Apostolova LG. Patient and caregiver reactions to clinical amyloid imaging. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 28174068 DOI: 10.1016/j.jalz.2017.01.001  0.01
2017 Grill JD, Holbrook A, Pierce A, Hoang D, Gillen DL. Attitudes toward Potential Participant Registries. Journal of Alzheimer's Disease : Jad. PMID 28106553 DOI: 10.3233/JAD-160873  0.01
2017 Cox CG, Gillen DL, Grill JD. [P4-012]: HOW DO PEOPLE WITH MILD COGNITIVE IMPAIRMENT AND THEIR FAMILY MEMBERS DECIDE WHETHER TO ENROLL IN PRODROMAL ALZHEIMER's DISEASE CLINICAL TRIALS? Alzheimer's & Dementia. 13: P1258-P1258. DOI: 10.1016/j.jalz.2017.06.1876  0.01
2016 Apostolova LG, Haider JM, Goukasian N, Rabinovici GD, Chételat G, Ringman JM, Kremen S, Grill JD, Restrepo L, Mendez MF, Silverman DH. Critical review of the Appropriate Use Criteria for amyloid imaging: Effect on diagnosis and patient care. Alzheimer's & Dementia (Amsterdam, Netherlands). 5: 15-22. PMID 28054024 DOI: 10.1016/j.dadm.2016.12.001  0.01
2016 Lin A, Brook J, Grill JD, Teng E. Participant-Informant Relationships Affect Quality of Life Ratings in Incipient and Clinical Alzheimer Disease. The American Journal of Geriatric Psychiatry : Official Journal of the American Association For Geriatric Psychiatry. PMID 27818119 DOI: 10.1016/j.jagp.2016.10.007  0.01
2016 Boise L, Hinton L, Rosen HJ, Ruhl MC, Dodge H, Mattek N, Albert M, Denny A, Grill JD, Hughes T, Lingler JH, Morhardt D, Parfitt F, Peterson-Hazan S, Pop V, et al. Willingness to Be a Brain Donor: A Survey of Research Volunteers From 4 Racial/Ethnic Groups. Alzheimer Disease and Associated Disorders. PMID 27779492 DOI: 10.1097/WAD.0000000000000174  0.01
2016 Grill JD, Apostolova LG, Bullain SS, Burns JM, Cox C, Dick M, Hartley D, Kawas CH, Kremen S, Lingler J, Lopez OL, Lundebjerg N, Mapstone M, Pierce A, Rabinovici GD, et al. P4-328: Communicating Mild Cognitive Impairment Diagnosis with and Without Amyloid Imaging: Recommendations From An Expert Workgroup Alzheimer's & Dementia. 12: P1160-P1160. DOI: 10.1016/j.jalz.2016.07.072  0.01
2016 Zhou Y, Elashoff D, Kremen S, Teng E, Karlawish J, Grill JD. P3-006: Racial Differences in Willingness to Enroll in Preclinical Alzheimer's Disease Clinical Trials Alzheimer's & Dementia. 12: P819-P820. DOI: 10.1016/j.jalz.2016.06.1663  0.01
2015 Coric V, Salloway S, van Dyck CH, Dubois B, Andreasen N, Brody M, Curtis C, Soininen H, Thein S, Shiovitz T, Pilcher G, Ferris S, Colby S, Kerselaers W, Dockens R, ... ... Grill JD, et al. Targeting Prodromal Alzheimer Disease With Avagacestat: A Randomized Clinical Trial. Jama Neurology. 1-10. PMID 26414022 DOI: 10.1001/jamaneurol.2015.0607  0.01
2015 Grill JD, Bateman RJ, Buckles V, Oliver A, Morris JC, Masters CL, Klunk WE, Ringman JM. A survey of attitudes toward clinical trials and genetic disclosure in autosomal dominant Alzheimer's disease. Alzheimer's Research & Therapy. 7: 50. PMID 26203303 DOI: 10.1186/s13195-015-0135-0  0.01
2015 Sperling RA, Karlawish J, Grill JD, Burns JM, Sultzer D, Johnson KA, Aisen PS. F3-03-03: Disclosure of amyloid status in the a4 trial Alzheimer's & Dementia. 11: P215-P215. DOI: 10.1016/j.jalz.2015.07.232  0.01
2015 Grill JD. S3-02-04: Ethics in Alzheimer's disease prevention clinical trial design Alzheimer's & Dementia. 11: P211-P211. DOI: 10.1016/j.jalz.2015.07.221  0.01
2015 Grill JD, Zhou Y, Elashoff D, Karlawish J. P3-310: The requirement to learn amyloid status is not a barrier to enrollment in preclinical Alzheimer's disease clinical trials Alzheimer's & Dementia. 11: P756-P756. DOI: 10.1016/j.jalz.2015.06.1684  0.01
2014 Grill JD, Raman R, Ernstrom K, Dowsett S, Hake A, Aisen P, Doody R, Cummings J. P4-174: COMPARING RECRUITMENT AMONG GEOGRAPHIC REGIONS IN MULTINATIONAL ALZHEIMER'S DISEASE CLINICAL TRIALS Alzheimer's & Dementia. 10: P852-P853. DOI: 10.1016/j.jalz.2014.05.1691  0.01
2014 Grill JD, Zhou Y, Karlawish J, Elashoff D. P4-173: THE IMPACT OF STUDY PARTNER CHANGE IN ALZHEIMER'S DISEASE RESEARCH Alzheimer's & Dementia. 10: P852-P852. DOI: 10.1016/j.jalz.2014.05.1690  0.01
2013 Grill JD, Johnson DK, Burns JM. Should we disclose amyloid imaging results to cognitively normal individuals? Neurodegenerative Disease Management. 3: 43-51. PMID 25285157 DOI: 10.2217/nmt.12.75  0.01
2012 Dilley M, Mason K, Silverman D, Quach J, Beigi M, Ringman J, Cummings J, Grill J. P1-171: Ketogenic medical food consumption in Alzheimer's disease enhances the acute cerebral blood flow response in specific frontocortical and basal ganglia regions Alzheimer's & Dementia. 8: P168-P168. DOI: 10.1016/j.jalz.2012.05.449  0.01
2012 Dosanjh K, Di L, Kotlerman J, Elashoff D, Ringman J, Grill J. P3-370: A pilot survey to explore attitudes toward primary prevention, secondary prevention and Alzheimer's disease treatment clinical trials Alzheimer's & Dementia. 8: P586-P586. DOI: 10.1016/j.jalz.2012.05.1595  0.01
2012 Grill J, Raman R, Ernstrom K, Aisen P, Karlawish J. P3-369: Alzheimer's disease patients with adult child study partners are underrepresented in clinical trials and may experience slower cognitive decline Alzheimer's & Dementia. 8: P585-P586. DOI: 10.1016/j.jalz.2012.05.1594  0.01
2010 Woo E, Lu PH, Grill J, Cummings JL. P2-148: Neuropsychiatric symptom profiles in Mild Cognitive Impairment and Alzheimer's disease Alzheimer's & Dementia. 6: S357-S357. DOI: 10.1016/j.jalz.2010.05.1195  0.01
Hide low-probability matches.